Cerebral delivery of redox-responsive lenalidomide prodrug plus methotrexate for primary central nerve system lymphoma combination therapy.
J Control Release
; 359: 132-146, 2023 07.
Article
in En
| MEDLINE
| ID: mdl-37269965
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Brain Neoplasms
/
Prodrugs
/
Central Nervous System Neoplasms
/
Lymphoma
Limits:
Humans
Language:
En
Journal:
J Control Release
Journal subject:
FARMACOLOGIA
Year:
2023
Document type:
Article
Affiliation country:
China
Country of publication:
Netherlands